O-(2-[18F]fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications.
about
Brain tumorsMetabolism of no-carrier-added 2-[18F]fluoro-L-tyrosine in rats.The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy.Diagnostics of cerebral gliomas with radiolabeled amino acids.3'-Deoxy-3'-[(18)F]fluorothymidine and O-(2-[(18)F]fluoroethyl)-L-tyrosine PET in Patients with Suspicious Recurrence of Glioma after Multimodal Treatment: Initial Results of a Retrospective Comparative StudyThe use of longitudinal 18F-FET MicroPET imaging to evaluate response to irinotecan in orthotopic human glioblastoma multiforme xenograftsRadiosyntheses using fluorine-18: the art and science of late stage fluorination[(18)F](2S,4S)-4-(3-Fluoropropyl)glutamine as a tumor imaging agent.The impact of 18 F-FET PET-CT on target definition in image-guided stereotactic radiotherapy in patients with skull base lesionsAn alternative and expedient synthesis of radioiodinated 4-iodophenylalanine.An intra-individual comparison of MRI, [18F]-FET and [18F]-FLT PET in patients with high-grade gliomas.Diesterified derivatives of 5-iodo-2'-deoxyuridine as cerebral tumor tracers.From the clinician's point of view - What is the status quo of positron emission tomography in patients with brain tumors?Synthesis, Radiolabeling, and Biological Evaluation of (R)- and (S)-2-Amino-5-[(18)F]fluoro-2-methylpentanoic Acid ((R)-, (S)-[(18)F]FAMPe) as Potential Positron Emission Tomography Tracers for Brain Tumors.Development of tyrosine-based radiotracer 99mTc-N4-Tyrosine for breast cancer imaging.Kinetic Modeling and Graphical Analysis of 18F-Fluoromethylcholine (FCho), 18F-Fluoroethyltyrosine (FET) and 18F-Fluorodeoxyglucose (FDG) PET for the Fiscrimination between High-Grade Glioma and Radiation Necrosis in Rats.Synthesis and evaluation of 18F labeled alanine derivatives as potential tumor imaging agentsAmino acid transport system - A substrate predicts the therapeutic effects of particle radiotherapy.Prediction of oligodendroglial histology and LOH 1p/19q using dynamic [(18)F]FET-PET imaging in intracranial WHO grade II and III gliomas.Contribution of (18)F-Fluoro-ethyl-tyrosine Positron Emission Tomography to Target Volume Delineation in Stereotactic Radiotherapy of Malignant Cranial Base Tumours: First Clinical ExperienceRadiosynthesis and biological evaluation of alpha-[F-18]fluoromethyl phenylalanine for brain tumor imagingMonitoring of Tumor Growth with [(18)F]-FET PET in a Mouse Model of Glioblastoma: SUV Measurements and Volumetric Approaches.Relapse patterns after radiochemotherapy of glioblastoma with FET PET-guided boost irradiation and simulation to optimize radiation target volume.Effect of α-Methyl versus α-Hydrogen Substitution on Brain Availability and Tumor Imaging Properties of Heptanoic [F-18]Fluoroalkyl Amino Acids for Positron Emission Tomography (PET).18F-AFETP, 18F-FET, and 18F-FDG imaging of mouse DBT gliomas.Integrated-boost IMRT or 3-D-CRT using FET-PET based auto-contoured target volume delineation for glioblastoma multiforme--a dosimetric comparison.Synthesis and evaluation of ¹⁸F labeled FET prodrugs for tumor imaging.Intra-individual comparison of ¹⁸F-FET and ¹⁸F-DOPA in PET imaging of recurrent brain tumors.Methods for (11) C- and (18) F-labelling of amino acids and derivatives for positron emission tomography imaging.Amino acid PET and MR perfusion imaging in brain tumours.(18)F-fluoroethyl-L-tyrosine positron emission tomography for the differential diagnosis of tumefactive multiple sclerosis versus glioma: A case reportInfluence of blood-brain barrier permeability on O-(2-18F-fluoroethyl)-L-tyrosine uptake in rat gliomas.System a amino acid transport-targeted brain and systemic tumor PET imaging agents 2-amino-3-[(18)F]fluoro-2-methylpropanoic acid and 3-[(18)F]fluoro-2-methyl-2-(methylamino)propanoic acid.Synthesis and preliminary biological evaluation of O-2((2-[(18)F]fluoroethyl)methylamino)ethyltyrosine ([(18)F]FEMAET) as a potential cationic amino acid PET tracer for tumor imaging.Imaging tumour ATB0,+ transport activity by PET with the cationic amino acid O-2((2-[18F]fluoroethyl)methyl-amino)ethyltyrosine.Population Pharmacokinetic Approach Applied to Positron Emission Tomography: Computed Tomography for Tumor Tissue Identification in Patients with Glioma.Synthesis, radiolabeling, and biological evaluation of (R)- and (S)-2-amino-3-[(18)F]fluoro-2-methylpropanoic acid (FAMP) and (R)- and (S)-3-[(18)F]fluoro-2-methyl-2-N-(methylamino)propanoic acid (NMeFAMP) as potential PET radioligands for imaging bSynthesis, uptake mechanism characterization and biological evaluation of (18)F labeled fluoroalkyl phenylalanine analogs as potential PET imaging agents.(18)F-FET and (18)F-FCH uptake in human glioblastoma T98G cell lines.Reproducibility of O-(2-(18)F-fluoroethyl)-L-tyrosine uptake kinetics in brain tumors and influence of corticoid therapy: an experimental study in rat gliomas.
P2860
Q24605136-E5CF23C8-B98A-473A-8CD9-B90EB82D827EQ30850780-2F2B73FD-8B39-4409-BB03-947292C0A2AFQ31156299-ACBE53B1-6F46-47C1-B13D-9DC5FC901117Q33487194-83CF4393-E48A-4D1C-B57C-3D9C11142823Q33704202-EA24F261-DB71-4A23-9912-2726DED7F9E7Q33740417-07599F11-E6DA-4261-8453-CDF6814B1871Q34074437-E6CF08F6-F90C-4C4A-B7B1-547156A28376Q34473613-6F1FF666-4531-4E48-B0F4-FAD92BF4D114Q35093266-AFF69162-650A-462F-8584-7C1492B36E8BQ35147811-68686CB2-3ABA-42D1-A124-BBB7F65CFF76Q35156126-0D5D940E-2984-415D-96DF-AE800E478EF1Q35207537-4BA9AB80-BD90-45C8-B553-4A3731E63399Q35679377-C26C7F7D-6D54-4F4A-AF9D-EFE64B323E7AQ35764792-391BDE65-CCC9-4ED4-8BA5-5EC7C852A0D0Q35830245-629D0F59-8FF3-4144-B629-AD51F1DA2BE9Q36112565-CB9952A7-A57C-4455-829F-BD29D86C76D2Q36205180-B1DABE81-01EB-4B9A-8678-62A5C8A681BFQ36293010-9D2353D9-0D66-435B-9BB6-58988628FC9CQ36401835-FC8F0FEA-F8CD-4E5E-9F00-1AE3CC4F99E0Q36413724-9CB62187-B4F7-4FCA-A1AC-0FD72001044DQ36816606-0CDED4F4-91F0-4AA9-A44D-AC5925481F31Q37000245-75789F73-A607-47D3-A6CB-7AFA3263E1CBQ37037922-36599202-732D-4EBF-A6F1-D366D9B6490EQ37118914-6AED506B-9B36-4753-8C5B-EBA309334329Q37155873-C5387400-4D4F-403D-8B6B-50A7920F63CCQ37455074-37A1DA34-36D0-4EF3-ABED-44142FC6162AQ37494311-537A9E0A-0043-4321-9A59-D189B95E5F60Q37580486-EB21C9C5-1AD2-416F-BBE0-6E743C283534Q38166978-C5C5B9EB-EADD-4D8F-8A3A-4DC956A833F4Q38691946-D315F6FF-7AF8-468A-B51D-5EE6DC068D59Q38720940-3677D828-CE47-4D40-89E4-DFF99F5F300FQ38747089-1CEE8384-4803-46EE-9558-5078AFB24B32Q38952620-33F858DE-0BE6-4DCC-B050-382301CE0C4CQ38997841-535391A0-3ECE-4D0B-88DA-8CF8E4466AF1Q39048536-815D5D11-34CD-46A7-88DE-1A3CFE4CCADAQ39084819-4990C3EE-4FD5-4386-BD34-BAA191E21B4CQ39557749-39F36A3B-B6EF-4186-BDF3-FCE48D334D66Q39609869-E6950358-FA0E-4E1B-BC95-E1A8D9528137Q39719750-1925BC63-2104-4F80-99FD-F86985ED2B8DQ40232491-135BB1EF-3593-47A6-8E20-A3D7B2AC3D64
P2860
O-(2-[18F]fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
O-(2-[18F]fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications.
@ast
O-(2-[18F]fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications.
@en
type
label
O-(2-[18F]fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications.
@ast
O-(2-[18F]fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications.
@en
prefLabel
O-(2-[18F]fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications.
@ast
O-(2-[18F]fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications.
@en
P2093
P1476
O-(2-[18F]fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications
@en
P2093
Dagmar Bauer
Dirk Pauleit
Frank Floeth
Heinz H Coenen
Kurt Hamacher
Matthias Weckesser
P304
P356
10.1016/J.NUCMEDBIO.2006.01.002
P577
2006-04-01T00:00:00Z